Global Monoclonal Antibodies In Veterinary Health Market Size & Outlook

The monoclonal antibodies in veterinary health industry worldwide is expected to reach a projected revenue of US$ 2,419.8 million by 2030. A compound annual growth rate of 17.1% is expected of the worldwide monoclonal antibodies in veterinary health industry from 2024 to 2030.
Revenue, 2023 (US$M)
$802.0
Forecast, 2030 (US$M)
$2,419.8
CAGR, 2024 - 2030
17.1%
Report Coverage
Worldwide

Global monoclonal antibodies in veterinary health market, 2018-2030 (US$M)

Global monoclonal antibodies in veterinary health market highlights

  • The global monoclonal antibodies in veterinary health market generated a revenue of USD 802.0 million in 2023 and is expected to reach USD 2,419.8 million by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of 17.1% by 2030.
  • In terms of segment, dogs accounted for a revenue of USD 553.7 million in 2023.
  • Dogs is the most lucrative animal type segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2023.
  • Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.

Global data book summary

Market revenue in 2023USD 802.0 million
Market revenue in 2030USD 2,419.8 million
Growth rate17.1% (CAGR from 2023 to 2030)
Largest segmentDogs
Fastest growing segmentDogs
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDogs

Other key industry trends

  • In terms of revenue, the North America accounted for 43.5% of the global monoclonal antibodies in veterinary health market in 2023.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, U.S. is the fastest growing regional market and is projected to reach USD 803.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Monoclonal Antibodies In Veterinary Health Market Scope

Monoclonal Antibodies In Veterinary Health Market Companies

Name Profile # Employees HQ Website

Global monoclonal antibodies in veterinary health market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to monoclonal antibodies in veterinary health market will help companies and investors design strategic landscapes.


Dogs was the largest segment with a revenue share of 69.04% in 2023. Horizon Databook has segmented the Global monoclonal antibodies in veterinary health market based on dogs covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Monoclonal Antibodies In Veterinary Health Animal Type Outlook (Revenue, USD Million, 2018-2030)
    • Dogs
    • Others
  • Global Monoclonal Antibodies In Veterinary Health Application Outlook (Revenue, USD Million, 2018-2030)
    • Dermatology
    • Pain
    • Others
  • Global Monoclonal Antibodies In Veterinary Health End User Outlook (Revenue, USD Million, 2018-2030)
    • Veterinary Hospitals
    • Others

Reasons to subscribe to Global monoclonal antibodies in veterinary health market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global monoclonal antibodies in veterinary health market databook

  • Our clientele includes a mix of monoclonal antibodies in veterinary health market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global monoclonal antibodies in veterinary health market , including forecasts for subscribers. This global databook contains high-level insights into Global monoclonal antibodies in veterinary health market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global monoclonal antibodies in veterinary health market size, by regions, 2018-2030 (US$M)

Top 10 countries: Monoclonal antibodies in veterinary health market size, 2023 (US$M)

Global monoclonal antibodies in veterinary health market share, by animal type, 2023 & 2030 (%, US$M)

Monoclonal antibodies in veterinary health market: Opportunity assessment by country

Global monoclonal antibodies in veterinary health market, by region, 2023 (US$M)

Global monoclonal antibodies in veterinary health market size, by regions, 2018-2030 (US$M)

Animal Type 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 CAGR
North America 208.3 227.3 249.9 276.6 308.4 348.7 397.1 455.3 525.6 610.9 714.8 842.0 998.6 16.2%
Europe 159.2 173.7 191.0 211.5 235.9 266.8 303.9 348.5 402.4 467.8 547.6 645.3 765.5 16.3%
Asia Pacific 61.6 70.0 80.0 92.1 106.7 125.2 147.8 175.6 209.9 252.4 305.4 371.7 455.3 20.3%
Latin America 20.3 22.5 25.1 28.3 32.0 36.8 42.6 49.7 58.3 68.9 81.9 98.1 118.2 18.1%
MEA 12.9 14.5 16.3 18.5 21.1 24.5 28.5 33.5 39.5 47.0 56.3 67.8 82.3 18.9%
Overall 462.2 508.0 562.3 627.0 704.1 802.0 919.9 1,062.5 1,235.7 1,446.9 1,705.9 2,024.9 2,419.8 17.1%

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more